The FDA lists BPC-157 among bulk drug substances that may present significant safety risks in compounding, citing concerns such as immune reactions, peptide-related impurities, and limited safety information
BPC-157 Side Effects in Oral Research Use BPC-157 is generally regarded as having a favorable safety profile, particularly in preclinical studies involving animals
Celia has been amazing in helping me understand exactly what all Im doing to improve my health
IV doses are 1000-2000 mcg
NAD+ Synergy Because it "plugs the leak" of NAD+ precursors, 5-Amino-1MQ is frequently studied in combination with NAD+ boosters like NMN or NR to maximize cellular energy and mitochondrial health
It has gained significant attention in research settings for its potential role in tissue repair, angiogenesis, and gut health mechanisms in preclinical models